Literature DB >> 25897784

Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.

Gabriella Guarnieri1, Elisabetta Zanatta2, Paola Mason1, Maria Cristina Scarpa1, Erika Pigatto2, Piero Maestrelli3, Franco Cozzi2.   

Abstract

OBJECTIVES: Lung diffusing capacity for carbon monoxide (DLCO) is impaired in interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) associated to systemic sclerosis (SSc), but the mechanism of DLCO reduction remains controversial. We hypothesised that the determinants of DLCO impairment differ in interstitial or vascular involvement of the lung of SSc patients.
METHODS: DLCO was partitioned into alveolar-capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) using combined single-breath DLNO and DLCO measurements. Seventeen SSc patients without pulmonary involvement (SSc), 20 SSc patients with ILD (SSc-ILD), with and without PAH, and 21 healthy controls were included.
RESULTS: DLNO and Dm were reduced in SSc patients as compared with controls, whereas Vc was not significantly different. SSc-ILD patients showed a highly significant decrease in Dm and Vc as compared with SSc patients and controls. Vc tended to be more reduced than Dm in SSc-ILD patients with PAH. Dm and Vc were negatively correlated with PAPs and HCRT scores, but the relationship with the HRCT score was stronger.
CONCLUSIONS: DLNO is more sensitive than DLCO in detecting functional impairment in SSc without radiologic or haemodynamic alterations. A disproportional reduction of Dm relative to Vc suggests a thickening of the blood-gas diffusion barrier in these patients. In SSc patients with detectable ILD, the gas exchange impairment is due to both components of lung diffusing capacity, and partitioning of DLCO in Dm and Vc is of little use in distinguishing the patients with only ILD from those with ILD complicated by PAH.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897784

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Optimizing the calculation of DM,CO and VC via the single breath single oxygen tension DLCO/NO method.

Authors:  Kirsten E Coffman; Bryan J Taylor; Alex R Carlson; Robert J Wentz; Bruce D Johnson
Journal:  Respir Physiol Neurobiol       Date:  2015-10-28       Impact factor: 1.931

2.  Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Authors:  Patricia Corzo; Anna Pros; Juana Martinez-Llorens; Luis Molina; Stephanie Fenxi Ling; Eva Balcells
Journal:  Clin Rheumatol       Date:  2018-10-27       Impact factor: 2.980

3.  Comparison of clinical and serological parameters in female and male patients with systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Dorota Suszek
Journal:  Reumatologia       Date:  2016-02-11

4.  Value of lung diffusing capacity for nitric oxide in systemic sclerosis.

Authors:  Giovanni Barisione; Alessandro Garlaschi; Mariaelena Occhipinti; Michele Baroffio; Massimo Pistolesi; Vito Brusasco
Journal:  Physiol Rep       Date:  2019-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.